Table 2.
Descriptive characteristics of patients enrolled in the study (n = 20)
| Patient characteristic | No. |
|---|---|
| Age, median (range) | 47 years (36–62) |
| Tumor size, median (range) | 20 mm (5–40) |
| Histopathology | |
| Ductal carcinoma in situ (DCIS) | 4 (20 %) |
| Invasive ductal carcinoma | 15 (75 %) |
| Invasive lobular carcinoma | 1 (5 %) |
| Axillary involvement in invasive carcinoma, n = 16 | 7 (43 %) |
| Molecular subtype of invasive carcinoma, n = 16 | |
| Luminal (A and B) | 11 (69 %) |
| Her2 | 1 (6 %) |
| Triple negative | 4 (25 %) |
| V2R status known, n = 18 | |
| Positive tumor expression | 6 (33 %) |
| Type of surgery | |
| Breast conserving surgery | 12 (60 %) |
| Mastectomy | 8 (40 %) |
| Postoperative adjuvant therapy | |
| None (DCIS) | 4 (20 %) |
| Cyclophosphamide-based chemotherapy | 6 (30 %) |
| Radiotherapy | 3 (15 %) |
| Chemoradiotherapy | 7 (35 %) |